Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 16/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7678825 | 0.95 | ADORA3 (1.00) | ADORA3ALDH1A1MAPTKDM4ERAB9A | |
| SCHEMBL7687342 | 0.87 | ADORA3 (0.83) | ADORA3NPSR1 | |
| SCHEMBL13780197 | 0.81 | ADORA3 (0.74) | ADORA3ALDH1A1MAPTKDM4ERAB9A | |
| SCHEMBL7685833 | 0.79 | ADORA3 (0.76) | ADORA3ALDH1A1MAPTKDM4ERAB9A | |
| SCHEMBL30741222 | 0.78 | ADORA3 (1.00) | ADORA3NPSR1 | |
| SCHEMBL6379843 | 0.78 | ADORA3 (1.00) | ADORA3NPSR1 | |
| SCHEMBL7681132 | 0.78 | ADORA3 (0.70) | ADORA3NPSR1 | |
| SCHEMBL7686721 | 0.78 | ADORA3 (1.00) | ADORA3ALDH1A1MAPTKDM4ERAB9A | |
| SCHEMBL7682869 | 0.78 | ADORA3 (0.65) | ADORA3NPSR1 | |
| SCHEMBL7680732 | 0.77 | ADORA3 (1.00) | ADORA3NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376521-B1 | ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2002-04-23 | — | — | US | disclosed |
| WO-2000002861-A1 | A3 ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-01-20 | — | — | WO | disclosed |